Cargando…
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel
SIMPLE SUMMARY: The combination of androgen deprivation therapy (ADT) with docetaxel (DX) or/and with novel anti-androgen receptor therapies have become standards for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC). However, metastatic PC remains incurable, and bi...
Autores principales: | Jiménez, Natalia, Reig, Òscar, Marín-Aguilera, Mercedes, Aversa, Caterina, Ferrer-Mileo, Laura, Font, Albert, Rodriguez-Vida, Alejo, Climent, Miguel Ángel, Cros, Sara, Chirivella, Isabel, Domenech, Montserrat, Figols, Mariona, González-Billalabeitia, Enrique, Jiménez Peralta, Daniel, Rodríguez-Carunchio, Leonardo, García-Esteve, Samuel, Garcia de Herreros, Marta, Ribal, Maria J., Prat, Aleix, Mellado, Begoña |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564355/ https://www.ncbi.nlm.nih.gov/pubmed/36230681 http://dx.doi.org/10.3390/cancers14194757 |
Ejemplares similares
-
Cell Plasticity-Related Phenotypes and Taxanes Resistance in Castration-Resistant Prostate Cancer
por: Jiménez, Natalia, et al.
Publicado: (2020) -
Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Taxanes
por: Marín-Aguilera, Mercedes, et al.
Publicado: (2021) -
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019) -
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
por: Mohr, Lisa, et al.
Publicado: (2017) -
Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study
por: Carles, J, et al.
Publicado: (2007)